blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2356989

EP2356989 - STABLE TABLET CONTAINING 4,5-EPOXYMORPHINAN DERIVATIVE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.12.2018
Database last updated on 21.09.2024
FormerThe patent has been granted
Status updated on  05.01.2018
FormerGrant of patent is intended
Status updated on  19.09.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): MK		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
Toray Industries, Inc.
1-1, Nihonbashi-Muromachi 2-chome Chuo-ku
Tokyo 103-8666 / JP
[2011/33]
Inventor(s)01 / OHTA, Kotoe
c/o Basic Research Laboratories
Toray Industries Inc.
10-1 Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
02 / TAKAKI, Suguru
c/o Basic Research Laboratories
Toray Industries Inc.
10-1 Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
03 / HORIUCHI, Yasuhide
c/o Basic Research Laboratories
Toray Industries Inc.
10-1 Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
 [2018/06]
Former [2011/33]01 / OHTA, Kotoe
c/o Basic Research Laboratories Toray Industries Inc. 10-1 Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
02 / TAKAKI, Suguru
c/o Basic Research Laboratories Toray Industries Inc. 10-1 Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
03 / HORIUCHI, Yasuhide
c/o Basic Research Laboratories Toray Industries Inc. 10-1 Tebiro 6-chome
Kamakura-shi Kanagawa 248-8555 / JP
Representative(s)Kador & Partner Part mbB
Corneliusstraße 15
80469 München / DE
[N/P]
Former [2018/06]Kador & Partner
Corneliusstraße 15
80469 München / DE
Former [2011/33]Kador & Partner
Corneliusstrasse 15
80469 München / DE
Application number, filing date09822078.323.10.2009
[2011/33]
WO2009JP68228
Priority number, dateJP2008027457924.10.2008         Original published format: JP 2008274579
[2011/33]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010047381
Date:29.04.2010
Language:JA
[2010/17]
Type: A1 Application with search report 
No.:EP2356989
Date:17.08.2011
Language:EN
[2011/33]
Type: B1 Patent specification 
No.:EP2356989
Date:07.02.2018
Language:EN
[2018/06]
Search report(s)International search report - published on:JP29.04.2010
(Supplementary) European search report - dispatched on:EP08.04.2013
ClassificationIPC:A61K31/485, A61K9/20
[2017/37]
CPC:
A61K9/2059 (EP,KR,US); A61K9/20 (KR); A61K31/485 (EP,KR,US);
A61K9/1623 (KR,US); A61K9/1676 (KR,US); A61K9/2009 (EP,KR,US);
A61K9/2018 (EP,KR,US); A61K9/2027 (EP,KR,US); A61P17/04 (EP) (-)
Former IPC [2013/18]A61K31/485, A61K9/20, A61K9/28, A61P17/04, A61K9/00
Former IPC [2011/33]A61K31/485, A61K9/20, A61K9/28, A61K47/02, A61K47/26, A61K47/32, A61K47/36, A61P17/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2018/06]
Former [2011/33]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:STABILE TABLETTE MIT 4,5-EPOXYMORPHINAN-DERIVAT[2011/33]
English:STABLE TABLET CONTAINING 4,5-EPOXYMORPHINAN DERIVATIVE[2011/33]
French:COMPRIMÉ STABLE CONTENANT UN DÉRIVÉ DE 4,5-ÉPOXYMORPHINANE[2011/33]
Entry into regional phase05.05.2011Translation filed 
05.05.2011National basic fee paid 
05.05.2011Search fee paid 
05.05.2011Designation fee(s) paid 
05.05.2011Examination fee paid 
Examination procedure05.05.2011Examination requested  [2011/33]
29.10.2013Amendment by applicant (claims and/or description)
20.09.2017Communication of intention to grant the patent
21.12.2017Fee for grant paid
21.12.2017Fee for publishing/printing paid
21.12.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.09.2017
Opposition(s)08.11.2018No opposition filed within time limit [2019/03]
Fees paidRenewal fee
28.10.2011Renewal fee patent year 03
31.10.2012Renewal fee patent year 04
28.10.2013Renewal fee patent year 05
28.10.2014Renewal fee patent year 06
27.10.2015Renewal fee patent year 07
25.10.2016Renewal fee patent year 08
25.10.2017Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY07.02.2018
EE07.02.2018
HR07.02.2018
LT07.02.2018
LV07.02.2018
MC07.02.2018
MK07.02.2018
SI07.02.2018
SK07.02.2018
SM07.02.2018
BG07.05.2018
NO07.05.2018
IS07.06.2018
LU23.10.2018
MT23.10.2018
[2020/31]
Former [2020/08]CY07.02.2018
EE07.02.2018
HR07.02.2018
LT07.02.2018
LV07.02.2018
MC07.02.2018
SI07.02.2018
SK07.02.2018
SM07.02.2018
BG07.05.2018
NO07.05.2018
IS07.06.2018
LU23.10.2018
MT23.10.2018
Former [2019/30]CY07.02.2018
EE07.02.2018
HR07.02.2018
LT07.02.2018
LV07.02.2018
MC07.02.2018
SI07.02.2018
SK07.02.2018
SM07.02.2018
BG07.05.2018
NO07.05.2018
IS07.06.2018
LU23.10.2018
Former [2019/28]CY07.02.2018
EE07.02.2018
HR07.02.2018
LT07.02.2018
LV07.02.2018
MC07.02.2018
SI07.02.2018
SK07.02.2018
SM07.02.2018
BG07.05.2018
NO07.05.2018
IS07.06.2018
Former [2019/13]CY07.02.2018
EE07.02.2018
HR07.02.2018
LT07.02.2018
LV07.02.2018
SI07.02.2018
SK07.02.2018
SM07.02.2018
BG07.05.2018
NO07.05.2018
IS07.06.2018
Former [2018/52]CY07.02.2018
EE07.02.2018
HR07.02.2018
LT07.02.2018
LV07.02.2018
SK07.02.2018
SM07.02.2018
BG07.05.2018
NO07.05.2018
IS07.06.2018
Former [2018/50]CY07.02.2018
EE07.02.2018
HR07.02.2018
LT07.02.2018
LV07.02.2018
SK07.02.2018
BG07.05.2018
NO07.05.2018
IS07.06.2018
Former [2018/41]CY07.02.2018
HR07.02.2018
LT07.02.2018
LV07.02.2018
BG07.05.2018
NO07.05.2018
IS07.06.2018
Former [2018/35]CY07.02.2018
HR07.02.2018
LT07.02.2018
NO07.05.2018
Documents cited:Search[IY]EP0948965  (TORAY INDUSTRIES [JP]) [I] 1-6 * the whole document * [Y] 1-6;
 [I]US6572891  (UGARKOVIC SONJA JOVAN [MK]) [I] 1-6 * abstract * * column 3, line 5 - line 8 * * column 5, line 12 - line 18; examples 1-5 *;
 [I]US2007196494  (GRENIER ARNAUD [FR], et al) [I] 1-6 * abstract *;
 [I]WO2008015220  (ETHYPHARM SA [FR], et al) [I] 1-6 * abstract * * page 19, line 1 - line 16; examples 2,4,8,10 *;
 [Y]  - S Edge, RW Miller, "Sodium Starch Glycolate", Handbook of Pharmaceutical Excipients, London, Pharmaceutical Press, (2006), pages 701 - 704, ISBN 0 85369 618 7, XP002694443 [Y] 1-6 * Section 11 Stability and Storage Conditions *
International searchWO9902158  [ ] (TORAY INDUSTRIES [JP], et al);
 EP0948965  [ ] (TORAY INDUSTRIES [JP]);
 US2001004637  [ ] (HANAMURA NOBUYUKI [JP], et al);
 [Y]JP2005002123  (TORAY INDUSTRIES)
 [Y]  - JAPAN PHARMACEUTICAL EXCIPIENTS COUNCIL, IYAKUHIN TENKABUTSU JITEN, (1994), page 31, 46
by applicantJPH02160719
 WO9315081
 JP2525552B
 WO9747287
 WO9835679
 WO9902158
 JP2002302446
 JP3531170B
 WO2004091623
 JP2005531515
 WO2006038661
 JP2007056011
 JP2007224021
    - "Kolldon Polyvnylpyrrolidon for the pharmaceutical industry", VOLKER BUEHLER, BASF brochure, (199308), pages 186 - 187
    - PATRICIA VAN ARNUM, "Advancing ODT Technology", PHARMACEUTICAL TECHNOLOGY, (20071002), vol. 3, no. 10, pages 66 - 76
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.